Production (Stage)
RAMM Pharma Corp.
RAMM
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 539.40K | 332.00K | 584.20K | 1.09M | 2.00M |
| Total Receivables | 1.16M | 1.20M | 1.18M | 1.21M | 1.40M |
| Inventory | 1.41M | 1.39M | 1.82M | 1.96M | 1.89M |
| Prepaid Expenses | 12.30K | 12.40K | 185.40K | 94.40K | 91.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 57.60K | 145.40K | 73.00K | 129.00K | 164.00K |
| Total Current Assets | 3.18M | 3.08M | 3.85M | 4.48M | 5.54M |
|
|
|||||
| Total Current Assets | 3.18M | 3.08M | 3.85M | 4.48M | 5.54M |
| Net Property, Plant & Equipment | 8.06M | 7.59M | 8.04M | 13.56M | 13.56M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 22.70K | 75.80K | 134.90K | 192.80K | 245.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 1.60M | 1.59M |
| Total Assets | 11.25M | 10.74M | 12.02M | 19.84M | 20.94M |
|
|
|||||
| Total Accounts Payable | 492.50K | 539.10K | 462.40K | 491.40K | 455.20K |
| Total Accrued Expenses | 146.90K | 143.30K | 257.00K | 206.10K | 208.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 31.30K | 84.00K | 74.30K | 109.80K | 142.90K |
| Total Finance Division Other Current Liabilities | 1.37M | 1.34M | 1.38M | 482.40K | 883.10K |
| Total Other Current Liabilities | 1.37M | 1.34M | 1.38M | 482.40K | 883.10K |
| Total Current Liabilities | 2.04M | 2.10M | 2.17M | 1.29M | 1.69M |
|
|
|||||
| Total Current Liabilities | 2.04M | 2.10M | 2.17M | 1.29M | 1.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 52.60K | 60.90K | 69.30K | 75.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.04M | 2.16M | 2.23M | 1.36M | 1.76M |
|
|
|||||
| Common Stock & APIC | 49.17M | 46.88M | 48.69M | 46.36M | 46.60M |
| Retained Earnings | -48.59M | -46.25M | -47.30M | -39.43M | -38.91M |
| Treasury Stock & Other | 8.63M | 7.95M | 8.39M | 11.55M | 11.48M |
| Total Common Equity | 9.22M | 8.59M | 9.78M | 18.48M | 19.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.22M | 8.59M | 9.78M | 18.48M | 19.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.22M | 8.59M | 9.78M | 18.48M | 19.17M |
|
|
|||||